GGrantIndex
← Leaderboards

Mamuka Kvaratskhelia

University Of Colorado Denver

$22,358,187
Attributed
$29,925,488
Total exposure
16
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY200625
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$29,925,488 · 16

By mechanism

R01$22,695,030 · 8
U54$2,732,701 · 2
T32$1,104,009 · 1
P50$1,022,499 · 1
P01$951,312 · 1
R21$826,726 · 2

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Top investigators on “Viral

Research focus

ViralHiv-1ComplexProteinsIntegraseBaseBiochemicalVirusTherapeutic TargetIntegrase InhibitorsStructureInhibitor/AntagonistPhenotypeInfectionBindingPlayViral DnaExperimental StudyRecombinantsFoundationsVirologyCapsidInnovationSmall Molecule

Grant awards (79)

Imaging early steps of HIV-1 infection and virus-host factor interactions$1,127,429
R01 · FY2025 · AI
Role of HIV-1 integrase in virion morphogenesis and its targeting by allosteric integrase inhibitors$802,476
R01 · FY2025 · AI · contact PI
Roles of HIV-1 capsid-binding FG-motif containing cellular cofactors in infection$753,963
R01 · FY2025 · AI · contact PI
Role of HIV-1 integrase in virion morphogenesis and its targeting by allosteric integrase inhibitors$847,141
R01 · FY2024 · AI · contact PI
Ultra-potent HIV capsid inhibitors$792,015
R01 · FY2024 · AI · contact PI
Roles of HIV-1 capsid-binding FG-motif containing cellular cofactors in infection$780,112
R01 · FY2024 · AI · contact PI
Imaging early steps of HIV-1 infection and virus-host factor interactions$564,977
R01 · FY2024 · AI
Training Program for Antiretroviral Discovery, Evaluation and Application Research (ADEAR)$201,858
T32 · FY2024 · AI
Ultra-potent HIV capsid inhibitors$792,015
R01 · FY2023 · AI · contact PI
Roles of HIV-1 capsid-binding FG-motif containing cellular cofactors in infection$782,859
R01 · FY2023 · AI · contact PI
Imaging early steps of HIV-1 infection and virus-host factor interactions$566,367
R01 · FY2023 · AI
Multimeric HIV-1 Integrase Inhibitors$498,192
R01 · FY2023 · AI · contact PI
Training Program for Antiretroviral Discovery, Evaluation and Application Research (ADEAR)$152,930
T32 · FY2023 · AI
Roles of HIV-1 capsid-binding FG-motif containing cellular cofactors in infection$813,266
R01 · FY2022 · AI · contact PI
Ultra-potent HIV capsid inhibitors$792,015
R01 · FY2022 · AI · contact PI
Imaging early steps of HIV-1 infection and virus-host factor interactions$582,057
R01 · FY2022 · AI
Multimeric HIV-1 Integrase Inhibitors$499,486
R01 · FY2022 · AI · contact PI
Training Program for Antiretroviral Discovery, Evaluation and Application Research (ADEAR)$234,484
T32 · FY2022 · AI
Ultra-potent HIV capsid inhibitors$792,015
R01 · FY2021 · AI · contact PI
Multimeric HIV-1 Integrase Inhibitors$500,757
R01 · FY2021 · AI · contact PI
Structural determinants for integrase pleiotropism in viral maturation$319,681
U54 · FY2021 · AI · contact PI
Training Program for Antiretroviral Discovery, Evaluation and Application Research (ADEAR)$259,371
T32 · FY2021 · AI
Ultra-potent HIV capsid inhibitors$819,765
R01 · FY2020 · AI · contact PI
Multimeric HIV-1 Integrase Inhibitors$502,002
R01 · FY2020 · AI · contact PI
Structure and function of HIV-1 integrase$401,319
R01 · FY2020 · AI · contact PI
Structural determinants for integrase pleiotropism in viral maturation$343,230
U54 · FY2020 · AI · contact PI
Training Program for Antiretroviral Discovery, Evaluation and Application Research (ADEAR)$255,366
T32 · FY2020 · AI
Multimeric HIV-1 Integrase Inhibitors$530,975
R01 · FY2019 · AI · contact PI
Structure and function of HIV-1 integrase$474,662
R01 · FY2019 · AI · contact PI
Structural determinants for integrase pleiotropism in viral maturation$372,998
U54 · FY2019 · AI · contact PI
Structural determinants for integrase pleiotropism in viral maturation$839,493
U54 · FY2018 · GM · contact PI
Structure and function of HIV-1 integrase$401,457
R01 · FY2018 · AI · contact PI
Multimeric HIV-1 Integrase Inhibitors$388,750
R01 · FY2018 · AI · contact PI
Core B: Proteomics and Protein Analysis Core$190,866
P01 · FY2018 · CA · contact PI
Structure and function of HIV-1 integrase$73,345
R01 · FY2018 · AI · contact PI
Core B: Proteomics and Protein Analysis Core$18,282
P01 · FY2018 · CA · contact PI
Structural determinants for integrase pleiotropism in viral maturation$857,299
U54 · FY2017 · GM · contact PI
Structure and function of HIV-1 integrase$386,140
R01 · FY2017 · AI · contact PI
Multimeric HIV-1 Integrase Inhibitors$379,359
R01 · FY2017 · AI · contact PI
Core B: Proteomics and Protein Analysis Core$190,157
P01 · FY2017 · CA · contact PI
Multimeric HIV-1 Integrase Inhibitors$44,633
R01 · FY2017 · AI · contact PI
Multimeric HIV-1 Integrase Inhibitors$499,421
R01 · FY2016 · AI · contact PI
Structure and function of HIV-1 integrase$412,060
R01 · FY2016 · AI · contact PI
Project 13$220,327
P50 · FY2016 · GM · contact PI
Core B: Proteomics and Protein Analysis Core$187,127
P01 · FY2016 · CA · contact PI
Multimeric HIV-1 Integrase Inhibitors$24,805
R01 · FY2016 · AI · contact PI
Multimeric HIV-1 Integrase Inhibitors$385,000
R01 · FY2015 · AI · contact PI
Project 13$202,911
P50 · FY2015 · GM · contact PI
Cellular Cofactors of Murine Leukemia Virus Integrase$192,500
R21 · FY2015 · AI · contact PI
Core B: Proteomics and Protein Analysis Core$188,770
P01 · FY2015 · CA · contact PI
Addae Supplement: Multimeric HIV-1 integrase inhibitors$57,175
R01 · FY2015 · AI · contact PI
Multimeric HIV-1 Integrase Inhibitors$384,792
R01 · FY2014 · AI · contact PI
Structual studies of HIV-1 integration$377,438
R01 · FY2014 · AI · contact PI
Cellular Cofactors of Murine Leukemia Virus Integrase$230,688
R21 · FY2014 · AI · contact PI
Project 13$194,814
P50 · FY2014 · GM · contact PI
Core B: Proteomics and Protein Analysis Core$176,110
P01 · FY2014 · CA · contact PI
Structual studies of HIV-1 integration$354,791
R01 · FY2013 · AI · contact PI
Project 13$190,376
P50 · FY2013 · GM · contact PI
Novel Assay for HIV-1 Integrase Inhibitors$377,438
R01 · FY2012 · AI · contact PI
Structual studies of HIV-1 integration$377,438
R01 · FY2012 · AI · contact PI
Project 13$214,071
P50 · FY2012 · GM · contact PI
HIV-1 Integrase Structure and Function as a Therapeutic Target$98,798
K02 · FY2012 · AI · contact PI
Novel Assay for HIV-1 Integrase Inhibitors$377,438
R01 · FY2011 · AI · contact PI
Structual studies of HIV-1 integration$377,438
R01 · FY2011 · AI · contact PI
HIV-1 Integrase Structure and Function as a Therapeutic Target$98,798
K02 · FY2011 · AI · contact PI
Novel Assay for HIV-1 Integrase Inhibitors$381,250
R01 · FY2010 · AI · contact PI
Structual studies of HIV-1 integration$381,250
R01 · FY2010 · AI · contact PI
HIV-1 Integrase Structure and Function as a Therapeutic Target$98,798
K02 · FY2010 · AI · contact PI
HIV-1 Integrase Structure and Function as a Therapeutic Target$49,983
K02 · FY2010 · AI · contact PI
Structural studies of HIV-1 integration$324,673
R01 · FY2009 · AI · contact PI
HIV-1 Integrase Structure and Function as a Therapeutic Target$98,798
K02 · FY2009 · AI · contact PI
HIV-1 Integrase Structure and Function as a Therapeutic Target$49,238
K02 · FY2009 · AI · contact PI
Structural studies of HIV-1 integration$325,844
R01 · FY2008 · AI · contact PI
HIV-1 Integrase Structure and Function as a Therapeutic Target$98,798
K02 · FY2008 · AI · contact PI
Structural studies of HIV-1 integration$278,159
R01 · FY2007 · AI · contact PI
HIV-1 Gag structure as a therapeutic target$254,038
R21 · FY2007 · AI · contact PI
Structural studies of HIV-1 integration$21,654
R01 · FY2007 · AI · contact PI
Structural studies of HIV-1 integration$287,417
R01 · FY2006 · AI · contact PI
HIV-1 Gag structure as a therapeutic target$149,500
R21 · FY2006 · AI · contact PI